ASIA BEAT: Talk vs action in the innovation mandate
This article was originally published in Scrip
Executive Summary
Effective government support for innovative R&D in the pharma/biotech sector was a keynote theme at the recent BioJapan conference in Yokohama, and a subject that threw the contrasting approaches of two Asian countries into sharp relief.